publicações selecionadas
-
artigo académico
- In vitro and in vivo evaluation of novel chromeno[2,3-d]pyrimidinones as therapeutic agents for triple negative breast cancer. RSC Medicinal Chemistry. 2024
- Effects of Lactate Transport Inhibition by AZD3965 in Muscle-Invasive Urothelial Bladder Cancer. Pharmaceutics. 2023
- Prognostic Value of Monocarboxylate Transporter 1 Overexpression in Cancer: A Systematic Review. International Journal of Molecular Sciences. 2023
- Synthesis and Biological Evaluation of Novel Chromeno[2,3-d]Pyrimidinones as Agents for Triple Negative Breast Cancer Treatment. European Journal of Medicinal Chemistry (IF 7.08, Q1 Chemistry, Organic). 2023
-
artigo de revista
-
documento
- Biological characterization of novel chromeno[2,3-d]pyrimidinones as therapeutic approach for the treatment of triple-negative Breast Cancer 2023
- Chromene-based molecules: privileged scaffold for oncology drug development 2023
- Effects of lactate transport inhibition by AZD3965 in muscle-invasive urothelial bladder cancer 2023
- In vitro and in vivo evaluation of novel chromeno[2,3-d]pyrimidinones as therapeutic agents for triple negative breast cancer 2023
- Avaliação in vitro e in vivo de novos cromeno[2,3-d]pirimidinonas como agentes terapêuticos para o cancro da mama triplo-negativo 2023
- Treatment of triple-negative breast cancer through externally triggered target-less drug carriers 2023
- Prognostic Value of Monocarboxylate Transporter 1 Overexpression in Cancer: A Systematic Review 2023
- In vitro validation of a new magnetic solid lipid nanoformulation against Triple-Negative Breast Cancer 2021
- Validation of a new nanoformulation for the diagnostic and treatment of triple-negative breast cancer 2021
- Validação de uma nova nanoformulação direcionada para o diagnóstico e tratamento do cancro da mama triplo-negativo 2021
- In vitro validation of new theranostic nanoformulation against Triple-negative breast cancer 2021
- In vitro validation of a new magnetic formulation against Trile-negative breast cancer 2021
- In vitro validation of a new magnetic formulation against Triple-Negative Breast Cancer 2021
- In vitro validation of a new theranostic nanoformulation against Triple-Negative Breast Cancer 2021
-
teses